Appropriate human papillomavirus vaccination strategies

The Lancet

Volumn 374, Issue 9698, 2009, Pages 1327-1328

  Tsu, Vivien ^a   Wittet, Scott ^a  

^a PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

CANCER IMMUNIZATION; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEPATITIS B; HUMAN; INFECTION PREVENTION; LETTER; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; VIRUS IMMUNITY; VIRUS TRANSMISSION; WART VIRUS;

FEMALE; HUMANS; MALE; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 70349871089     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61820-1     Document Type: Letter

References (5)

1. Michels K.B., and zur Hausen H. HPV vaccine for all. Lancet 374 (2009) 268-270
2. Ault K.A. Long-term efficacy of human papillomavirus vaccination. Gynecol Oncol 107 (2007) S27-S30
3. Goldie S. A public health approach to cervical cancer control: considerations of screening and vaccination strategies. Int J Gynaecol Obstet 94 (2006) S95-S105
4. Elbasha E.H., Dasbach E.J., and Insinga R.P. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 13 (2007) 28-41
5. Marra F., Cloutier K., Oteng B., Marra C., and Ogilvie G. Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics 27 (2009) 127-147